The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Discover the best nasal congestion home remedies, according to an ENT doctor who specializes in sinus and nasal disorders. Plus, learn what doesn't work.

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

The company's Phase 2A study of PH284 nasal spray showed promising results for treating cachexia in cancer patients, with the product improving patients' feelings of hunger and demonstrating a ...

To date Mesa received $4.5 million in One Arizona settlement funds. The city will give $1 million to nonprofits working to combat opioid use in Mesa.

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

But hidden at your pharmacy among the potpourri of cough drops and cold remedies, you can find a low-risk treatment that actually may help: nasal irrigation devices. Several small studies suggest ...

The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

Walgreens Boots Alliance and CVS Health are in the midst of turnarounds. This comes after both stocks have lost significant value in recent years. Both have new CEOs who are looking at options to ...